These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7704478)

  • 1. The immunological adjuvant and vaccine carrier properties of liposomes.
    Gregoriadis G
    J Drug Target; 1994; 2(5):351-6. PubMed ID: 7704478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes as carrier and immunoadjuvant of vaccine antigens.
    van Rooijen N
    Adv Biotechnol Processes; 1990; 13():255-79. PubMed ID: 2185785
    [No Abstract]   [Full Text] [Related]  

  • 3. Gel core liposomes: an advanced carrier for improved vaccine delivery.
    Tiwari S; Goyal AK; Khatri K; Mishra N; Vyas SP
    J Microencapsul; 2009 Feb; 26(1):75-82. PubMed ID: 18608797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannosylated liposomes for targeted vaccines delivery.
    Vyas SP; Goyal AK; Khatri K
    Methods Mol Biol; 2010; 605():177-88. PubMed ID: 20072881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine entrapment in liposomes.
    Gregoriadis G; McCormack B; Obrenovic M; Saffie R; Zadi B; Perrie Y
    Methods; 1999 Sep; 19(1):156-62. PubMed ID: 10525452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.
    Alving CR
    Immunobiology; 1993 Apr; 187(3-5):430-46. PubMed ID: 8330907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ; Deck RR; Liu MA
    J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice.
    Mazumder S; Ravindran R; Banerjee A; Ali N
    Vaccine; 2007 Dec; 25(52):8771-81. PubMed ID: 18031874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.
    Korsholm KS; Andersen PL; Christensen D
    Expert Rev Vaccines; 2012 May; 11(5):561-77. PubMed ID: 22827242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles.
    Gursel M; Gregoriadis G
    J Drug Target; 1998; 5(2):93-8. PubMed ID: 9588865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the adjuvant and cytotoxic effects of the positive charges and polymerization in liposomes.
    Gasparri J; Speroni L; Chiaramoni NS; del Valle Alonso S
    J Liposome Res; 2011 Jun; 21(2):124-33. PubMed ID: 20550461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid A and liposomes containing lipid A as antigens and adjuvants.
    Alving CR; Rao M
    Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Rosenkrands I; Lindenstrøm T; Andersen P; Agger EM
    Expert Rev Vaccines; 2007 Oct; 6(5):785-96. PubMed ID: 17931158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O
    Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine.
    Goodman MG
    Pharm Biotechnol; 1995; 6():581-609. PubMed ID: 7551237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages.
    van Rooijen N
    J Drug Target; 2008 Aug; 16(7):529-34. PubMed ID: 18686122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
    J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.